SWAlexander
Senior Member
- Messages
- 2,053
excerpt:
Two physicians who treat patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) have issued a statement expressing gratitude for the recent National Institutes of Health's "deep phenotyping" study of the condition that identified several distinct biologic abnormalities but also criticized some aspects of the study and the way the findings were reported.
One of the statement's authors, Lucinda Bateman, MD, founder and medical director of the Bateman Horne Clinic (BHC) in Salt Lake City, Utah, was an independent case adjudicator for the study but had no role in the data analysis or the publication. The other statement author, Brayden Yellman, MD, is a BHC medical provider.
The two issued the statement in response to "a whirlwind of impassioned commentary" about the study on social media and elsewhere, much of it around the use of the term "effort preference" to describe results from one of the study tests and the lack of focus on the hallmark ME/CFS symptom post-exertional malaise (PEM). All 17 of the study patients experienced PEM, a core criterion of the 2015 Institute of Medicine's ME/CFS case definition.
continue: https://www.medscape.com/viewarticl...t_tpal_etid6344320&uac=427271HY&impID=6344320
my comment:
“We found naive T cells and B cells were activated, and the anti-programmed death-1 level was elevated.”
It's amazing to me that, although naive T cells and B cells are mentioned, and not for the first time, no Thymus MRT is presented.
Two physicians who treat patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) have issued a statement expressing gratitude for the recent National Institutes of Health's "deep phenotyping" study of the condition that identified several distinct biologic abnormalities but also criticized some aspects of the study and the way the findings were reported.
One of the statement's authors, Lucinda Bateman, MD, founder and medical director of the Bateman Horne Clinic (BHC) in Salt Lake City, Utah, was an independent case adjudicator for the study but had no role in the data analysis or the publication. The other statement author, Brayden Yellman, MD, is a BHC medical provider.
The two issued the statement in response to "a whirlwind of impassioned commentary" about the study on social media and elsewhere, much of it around the use of the term "effort preference" to describe results from one of the study tests and the lack of focus on the hallmark ME/CFS symptom post-exertional malaise (PEM). All 17 of the study patients experienced PEM, a core criterion of the 2015 Institute of Medicine's ME/CFS case definition.
continue: https://www.medscape.com/viewarticl...t_tpal_etid6344320&uac=427271HY&impID=6344320
my comment:
“We found naive T cells and B cells were activated, and the anti-programmed death-1 level was elevated.”
It's amazing to me that, although naive T cells and B cells are mentioned, and not for the first time, no Thymus MRT is presented.
Last edited: